Gregory J. Gores, M.D. is a senior physician scientist. His research contributions include sustained federal funding over three decades (over 80 projects and 21 million in funding), over 750 publications, an H-index of 158 with over 83,000 citations (Scopus data base). His clinical focus on hepatobiliary neoplasia has led to novel protocols regarding liver transplantation for cholangiocarcinoma. Educational activities include mentoring over 81 fellows, and directing a liver transplant fellowship program.

Dr. Erica Johnson, board-certified in internal medicine and infectious disease, joined ABIM as its Senior Vice President for Academic and Medical Affairs in October 2024. Prior to this role, she served as the Program Director for the Internal Medicine Residency at Johns Hopkins Bayview Medical Center and Associate Vice Chair for Diversity, Equity and Inclusion in Medical Education for the Johns Hopkins Department of Medicine in Baltimore, Maryland. She remains on faculty at Johns Hopkins as Associate Professor of Medicine (part time) in the Division of Infectious Diseases.

Dr, Ghabril is a Hepatologist at Indiana University. He has a clinical and research interest in drug-induced liver injury, and is an investigator in the Drug-Induced Liver Injury Network. He is the Program Director of the Transplant Hepatology Fellowship at IUSM, and Director of the Liver Inpatient Service at Indiana University Hospital.

Emily Cartwright is an Associate Professor in the Division of Infectious Diseases at Emory University. She is board certified in Internal Medicine and Infectious Diseases and received additional training as an Epidemic Intelligence Officer at the Centers for Disease Control and Prevention (CDC). She is a staff physician at the Atlanta VA medical center where she directs the Hepatitis C program and she also works as a medical officer on the Clinical Interventions Team in the Division of Viral Hepatitis at CDC.

Dr. Linas is an Infectious Diseases physician scientist focused on the overlapping epidemics (syndemic) of substance use disorders and infectious diseases. His research investigates the comparative- and cost-effectiveness of interventions to identify and treat OUD, HIV, HCV, and serious bacterial infections in the real-world, where resources are limited and the best strategies for obtaining good outcomes are not certain. Dr. Linas works closely with the U.S.

Andrew Aronsohn is an Associate Professor of Medicine in the Center for Liver Diseases at the University of Chicago Medical Center. Dr. Aronsohn serves as the chief of hepatology as well as the program director of the gastroenterology fellowship. Dr. Aronsohn is a co-chair of the AASLD / IDSA HCV guidance and has a busy clinical practice, which includes both general and transplant hepatology.

Dr. Khaderi is a member of AASLD's Women's Initiative Committee and Education Lead of the HCV SIG.

Dr. Fenkel is a Professor of Medicine at Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia, PA, USA. He is the Director of the Jefferson Viral Hepatitis Center and Associate Medical Director of Liver Transplantation at Thomas Jefferson University Hospital.

Ms. Zapatka, MSN, APN-BC is currently the VA CT Healthcare System's (VACHS) Liver Resource Center's Nurse Practitioner. Susan was the NP Co-Director for the Center of Excellence in Primary Care Education, and recipient of many nursing and academic awards, including Yale School of Medicine Internal Medicine Primary Care Residency Program – Support Staff Recognition Award and the CTAPRN NP of the Year Award.

My name is Anna Marie Hefner, PhD, RN, CPNP, FAASLD.. Her dissertation is entitled "A Descriptive Study of Nutritional Parameters in Patients with Cirrhosis. She is the Director of Nashville at a community-based liver center. We acknowledge each patient and work with the guidelines set forth with AASLD and the individual goals of the patient. We discussed their plan of action and meet them where they are at using the "HALO" approach-health and liver optimization. <br>I am a fellow of the ASSLD.